본문 바로가기
KERD
논문KCI 등재

결핵균 약제감수성 검사의 비용효율성에 관한다기관 연구

Multi-center Study on Cost Effectiveness of Anti-Tuberculosis Drug Susceptibility Test

0

조회

0

다운로드

3

인용

0

참고문헌

주제분류내과학

초록

목 적 : 우리나라에서의 결핵균 감수성 검사는 검출 균주의 일부에서만 시행되고 있다. 본 연구에서는 모든 검출 균주들에 대해서 감수성검사를 실시하면서, 진료에 필요한 결과를 충분히 제공하고 경제적이면서 현실적인 감수성검사 방안을 제시하고자 한다.재료 및 방법 : 5개 대학병원에서 일정기간 연속적으로 의뢰된 502균주의 감수성 결과를 분석하였다. 검사결과의 해석 및 2차 약제 감수성검사의 필요성은 NCCLS approved standard M24-A의 권고 기준에 따라 판단하였다.결 과 : 최소한 1가지 이상의 약제에 내성을 보인 경우는 초치료 환자의 10% (38/363), 재치료 환자의 61% (85/139)였으며, 다약제 내성을 보인 경우는 초치료 환자의 3% (11/363), 재치료 환자의 44% (61/139)였다. NCCLS 권고에 따라 2차 약제에 대한 감수성 검사를 시행하지 않아도 되는 경우는 초치료 환자의 96%, 재치료 환자의 47%였다.결 론:초치료 환자는 95%에서 1차 약제에 대한 검사만으로 충분하므로 필요한 경우에만 2차 약제를 추가로 검사하고 재치료 환자에서는 1, 2차 약제를 동시에 검사할 필요가 있을 것으로 생각한다.

Abstract

Background:The anti-mycobacterial susceptibility test is performed on only a small percentage of clinical isolates in Korea. The aim of this study is to propose an anti-mycobacterial susceptibility testing scheme, which is not only economic and practical but also fully informative to physicians. Materials and Methods:The anti-mycobacterial susceptibility test results of 502 strains, isolated from five university-affiliated hospitals, were analysed. The interpretation of the results and the need for second-line drug susceptibility test were judged according to the recommendation of NCCLS M24-A guidelines. Results:The isolates from 10% (38/363) of treatment-navie patients and 61% (85/139) of re- treatment patients showed resistance to at least one of the anti-mycobactial agents; 3% (11/363) and 44% (61/139) of isolates from each group were multi-drug resistant. According to the recommendation by NCCLS, the percentage of patients not needing the susceptibility test results for second-line drugs were 96% for treatment-naive and 47% for re-treatment patients. Conclusion:Since the susceptibility test against first-line drug is sufficient for 95% of treatment- navie patients with tuberculosis patients, susceptibility test against second-line drugs may be performed only when it is necessary. As for the re-treatment patients with tuberculosis, susceptibility test for both first-line and second-line drugs should be performed simultaneously.

참고문헌 (18)

  1. "Diagnosis and susceptibility testing. In : Schlossberg D, ed. Tuberculosis and nontuberculous mycobacterial infections.", pp.57~64 (1999)
  2. "Antimicrobial susceptibility testing of difficult organisms - Mycobacterium tuberculosis", 7, pp.526~28 (2004)
  3. "Susceptibility testing of mycobacteria, Nocardiae, and other aerobic Actinomycetes; approved standard" (2003)
  4. "Identification tests for mycobacteria. In : Isenberg HD, ed. Clinical Microbiology Procedure Handbook", pp.17~13 (1995), ASM Press
  5. "An analysis of antituberculosis drug susceptibility test results in Kyung Hee Medical Center during recent four years", 7, pp.182~5 (2004)
  6. "An analysis of antituberculous drug susceptibility test results during 5 years", 12, pp.493~9 (1992)
  7. "An analysis of antituberulosis drug susceptibility test results in Kangwon area during recent four years", 15, pp.299~305 (1993)
  8. "Prevalence of drug-resistances in patients with pulmonary tuberculosis and its association with clinical characteristics at one tertiary referral hospital in Pusan,Korea", 51, pp.416~25 (2001)
  9. "Present and future laboratory test of mycobacteria - Clinician's view", 17, pp.~31 (1997)
  10. "Mycobacterial testing in hospital laboratories in Korea:Results of a survey of 40 University or tertiary-care hospitals", 19, pp.86~91 (1999)
  11. "Survey on changes in mycobacterial testing practices in Korean laboratories", 4, pp.108~14 (2001)
  12. "Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide and ethambutol and comparison with the radiometric BACTEC 460TB method", 42, pp.1109~14 (2004)
  13. "Multicenter evaluation of the MB", BACT system for susceptibility testing of Mycobacterium tuberculosis, 2004, pp.42, 1030~4
  14. "Evaluation of the BacT", ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis, 2003, pp.9, 1148~52
  15. "Simple procedure for drug susceptibility testing of Mycobacterium tuberculosis using a commercial colorimetic assay", 18, pp.380~3 (1999)
  16. "Comparison of the susceptibility testing of clinical isolates of Mycobacterium tuberculosis by the XTT colorimetric method and the NCCLS standards method", 21, pp.244~50 (2003)
  17. "Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis", 40, pp.1873~4 (2002)
  18. "Evaluation of a colorimetric assay based on 3- for rapid detection of rifampicin resistance in Mycobacterium tuberculosis", 2, pp.5 5 1011~6 (1998)

관련 논문AI추천

이 간행물의 다른 논문 (9건)